$MDGL

$440.33 +$2.59 (0.59%) Close

$MDGL Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 23.1M shares outstanding

Who owns MDGL?

By type of holder

Institutions 100.0% Insiders 0.0% Everyone else 0.0%

Concentration Top 10 holders own 68.0%

Baker Bros. Advisors LP 9.3% · RTW Investments, LP 8.6%

Institutional ownership

100.0%

0 pts vs last qtr

Institutional holders

411

+31 vs last qtr

Net shares bought

−357.1K

by institutions in Q2 2026

New / sold out

80 / 49

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Jupiter Topco LLC NEW +1.9M
UBS Group AG +283.9K

Biggest sellers in Q2 2026

Janus Henderson Group PLC SOLD OUT −2.0M
BlackRock, Inc. −359.2K

Who is planning to sell?

Notices of proposed sale, last 12 months

$108M

29 notices from 18 people

Shares covered

203.3K

0.88% of the company

Arranged in advance

82%

of the value is under a 10b5-1 plan

Under a 10b5-1 plan No plan

Largest proposed sellers

Paul Friedman Director 10b5-1 $53.3M
Rebecca A Taub Director 10b5-1 $20.7M

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2020–FY2025

+83.9%

+12.96% a year

Each share's claim on the business

−45.6%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $307M

over 6 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years51% 3–5 years18% 1–3 years14% Under 1 year17%

Quarterly turnover

18.7%

of institutional shares changed hands

Top 10 managers, median time held

5 years

Super Investors

Investment managers reporting MDGL on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
BB Baker Bros. Advisors LP	2.1M	9.28%	+1.4K (+0.1%)	≤2021	5.8%
Shares held by quarter Peak holding2.1M (Q2'26) Change over 8 quarters+168.5K Share of the company9.280% Baker Bros. Advisors LP's full portfolio →
JH Janus Henderson Group PLC	—	—	SOLD OUT	—	0.0%
Shares held by quarter Peak holding2.5M (Q3'24) Change over 8 quarters−2.5M Janus Henderson Group PLC's full portfolio →

Baker Bros. Advisors LP

2.1M

% of company

9.28%

Change vs last qtr

+1.4K (+0.1%)

Held since

≤2021

Janus Henderson Group PLC

—

% of company

—

Change vs last qtr

SOLD OUT

Held since

—

28 more super investors behind a free account

See every manager holding Madrigal Pharmaceuticals, Inc., how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting MDGL on Form N-PORT; together they hold 35.9% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$314M	585.0K	2.53%	0.01%	June 30, 2026
VH Vanguard Health Care Fund Vanguard Specialized Funds	$263M	563.1K	2.44%	0.69%	July 31, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$314M

% of company

2.53%

% of the fund

0.01%

As of

June 30, 2026

Vanguard Health Care Fund

Vanguard Specialized Funds

Position value

$263M

% of company

2.44%

% of the fund

0.69%

As of

July 31, 2026

23 more funds behind a free account

See every fund holding Madrigal Pharmaceuticals, Inc. and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
RT Rebecca Taub, M.D. 5%+ holder 13D · 7.8%	1.8M	7.86%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company7.860% Disclosed stake13D · 7.8% View the 13D/G filing →
PA Paul A Friedman, M.D. 5%+ holder 13D · 7.8%	1.8M	7.86%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company7.860% Disclosed stake13D · 7.8% View the 13D/G filing →

Rebecca Taub, M.D.

5%+ holder13D · 7.8%

1.8M

% of company

7.86%

Change vs last qtr

—

Held since

—

Paul A Friedman, M.D.

5%+ holder13D · 7.8%

1.8M

% of company

7.86%

Change vs last qtr

—

Held since

—

14 more holders behind a free account

See every insider and 5%+ holder of Madrigal Pharmaceuticals, Inc..

Comments